Lophos Pharmaceuticals Receives Controlled Substances Dealers License (CSDL) From Health Canada
NAPANEE, Ontario, Aug. 25, 2023 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. is pleased to announce that its wholly owned subsidiary, Lophos Pharmaceuticals Corp., has received its Controlled Substances Dealers License (CSDL) from Health Canada, effective as of August 23, 2023. The Controlled Substances Dealers License (CSDL) permits Lophos Pharmaceuticals to possess, produce, sell/provide, send, transport and deliver the controlled substances covered by the license, namely mescaline, psilocin and psilocybin.
Claire Stawnyczy, President of Lophos Holdings stated "this monumental achievement marks a pivotal point for Lophos Pharmaceuticals Corp., empowering the Company to further its dedication to advancing peyote research, development, and cultivation. The attainment of the Controlled Substances Dealers License (CSDL) stands as a testament to Lophos Pharmaceuticals' unwavering commitment to scientific excellence, ethical practices, and regulatory compliance in controlled substance handling."
Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of this release.
GALAXY TECHNOLOGY HIRES LLC, founded by former SpaceX, Talent Acquisition leader, Brandon Garrett, in 2015, has been announced as a 2024 Longhorn 100 winner. As one of the fastest growing Longhorn led businesses in the world, GalaxyTek specializes in...
Saul Centers, Inc. , an equity real estate investment trust ("REIT"), announced operating results for the quarter ended March 31, 2024 ("2024 Quarter"). Total revenue for the 2024 Quarter increased to $66.7 million from $63.0 million for the quarter...
The Lockheed Martin board of directors has authorized a second quarter 2024 dividend of $3.15 per share. The dividend is payable on June 28, 2024, to holders of record as of the close of business on June 3, 2024. ...
Orion S.A. , a specialty chemical company, today announced financial results for period ended March 31, 2024 as follows:
Three Months 2024 Highlights
Net sales of $502.9 million, up $2.2 million, year over year
Net income of $26.7 million,...
Trisura Group Ltd. ("Trisura" or "Trisura Group") , a leading specialty insurance provider, today announced financial results for the first quarter of 2024. David Clare, President and CEO of Trisura, stated, "Trisura demonstrated strong performance...